European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure
This guidance document addresses a number of questions which users of the centralised procedure may have. It provides an overview of the European Medicines Agency’s position on issues, which are typically addressed during the course of pre-submission meetings.
Click on this link for more information.
